Current Drug Targets - Cardiovascular & Hematological Disorders
Title: Editorial
Volume: 5 Issue: 1
Author(s): Alexandra Lucas
Affiliation:
Export Options
About this article
Cite this article as:
Lucas Alexandra, Editorial, Current Drug Targets - Cardiovascular & Hematological Disorders 2005; 5 (1) . https://dx.doi.org/10.2174/1568006053004976
DOI https://dx.doi.org/10.2174/1568006053004976 |
Print ISSN 1568-0061 |
Publisher Name Bentham Science Publisher |
Online ISSN 1568-0061 |
10
Related Articles
-
Treatment Considerations of Clinical Physician on Hypertension Management in Asia
Current Hypertension Reviews Gene Therapy for Ischemic Brain Diseases
Current Gene Therapy The Biology and Therapeutic Potential of the DDAH/ADMA Pathway
Current Pharmaceutical Design Vitamin D Supplementation and Cancer: Review of Randomized Controlled Trials
Anti-Cancer Agents in Medicinal Chemistry Selective Pharmacological Inhibition of the Pacemaker Channel Isoforms (HCN1-4) as New Possible Therapeutical Targets
Current Medicinal Chemistry Periodontitis, Endothelial Dysfunction and Atherosclerosis
Vascular Disease Prevention (Discontinued) Pharmacotherapy of Abdominal Aortic Aneurysms
Current Vascular Pharmacology 1h Post-load Blood Glucose in the Identification of Proatherogenic Cardiometabolic Profile in Obesity
Endocrine, Metabolic & Immune Disorders - Drug Targets Molecular Mechanisms Involved in the Aging of the T-cell Immune Response
Current Genomics Carotid and Vertebral Arterial Variations in Alzheimer's Disease
Current Alzheimer Research Pharmacological Management Options to Prevent and Reduce Ischemic Hemorrhagic Transformation
Current Drug Targets Gut Inflammation in Response to Injury: Potential Target for Therapeutic Intervention
Recent Patents on Anti-Infective Drug Discovery Pathophysiological Basis for Anticoagulant and Antithrombotic Therapy in Pulmonary Hypertension
Cardiovascular & Hematological Agents in Medicinal Chemistry Structural Alterations of the Retinal Microcirculation in the “Prehypertensive” High- Normal Blood Pressure State
Current Pharmaceutical Design SGLT-2 Inhibitors in Type 1 Diabetes Mellitus: A Comprehensive Review of the Literature
Current Clinical Pharmacology Correlation between Serum 25 hydroxy vitamin D level and plasminogen activator inhibitor 1 in type 2 diabetic patients
Endocrine, Metabolic & Immune Disorders - Drug Targets From Hybrids to New Scaffolds: The Latest Medicinal Chemistry Goals in Multi-target Directed Ligands for Alzheimer’s Disease
Current Neuropharmacology Homocysteine-Lowering Treatment in Coronary Heart Disease
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Noninvasive Diagnosis of Chemotherapy Related Cardiotoxicity
Current Cardiology Reviews P-Selectin Antagonism in Inflammatory Disease
Current Pharmaceutical Design